Fluidigm is now Standard BioTools Inc.
Improving human health through innovative medicines is your mission.
Our mission is to provide you with the right, reliable products to solve your problems.
Introducing Standard BioTools.
A company and a name that reflect our commitment to you, the researcher and inventor:
To unleash the power of essential, standardized tools that help the life science industry
develop breakthrough medicines faster and better.
Introducing the Hyperion+™ Imaging System
Advance efficiency with a simple stain-image-analyze workflow. Enable simultaneous phenotyping of 40-plus targets. Accelerate decisions from over 100 samples a week. A new standard for high-plex imaging.
Learn even more with expert input
on these powerful innovations.
May 16 - May 20
ISBER 2022 (International Society for Biological and Environmental Repositories) in Atlanta, GA
May 18 - May 21
3rd Alpenflow Meeting (Austrian Society of Cytometry)
Scientist in the Spotlight in collaboration with the EACR - Bernd Bodenmiller "Multiscale Analysis of Tumor Ecosystems Towards Precision Medicine"
Save the Date: Igniting Insight in Immuno-Oncology CyTOF® Flow Cytometry Virtual Summit
Jun 04 - Jun 08
ATC 2022 (American Transplant Congress) in Boston, MA
Scientist in the Spotlight - Ilaria Michelozzi High-dimensional functional phenotyping of preclinical human CAR T cells using mass cytometry
Jun 08 - Jun 10
SEASR Annual Meeting (Southeastern Association of Shared Resources) in Nashville, TN
Jun 14 - Jun 15
Save the Dates! Cytometry Powered by Time-of-Flight: Igniting Insight into Immuno-Oncology
Save the Date! Cytometry Powered by Time-of-Flight: Igniting Insight into Immuno-Oncology: CyTOF Summit, Tuesday, June 14
Save the Date! Cytometry Powered by Time-of-Flight: Igniting Insight into Immuno-Oncology: IMC Forum, Wednesday, June 15
Powerful. Intuitive. Transformative.
Empower the generation of meaningful answers to challenging questions, with proven microfluidics technology that can transform all PCR-based genomics studies. Imagine the possibilities, all on one platform.